Nplate® (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia Read more about Nplate® (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
EVENITY® (Romosozumab) Receives Positive CHMP Opinion For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture Read more about EVENITY® (Romosozumab) Receives Positive CHMP Opinion For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Sports Anchor And Multiple Myeloma Patient Rod Gilmore Joins Amgen's Myeloma MVP™ Team Read more about Sports Anchor And Multiple Myeloma Patient Rod Gilmore Joins Amgen's Myeloma MVP™ Team
Amgen Foundation Launches Amgen Biotech Experience In Pittsburgh Read more about Amgen Foundation Launches Amgen Biotech Experience In Pittsburgh
Amgen Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Patients With Solid Tumors At ESMO 2019 Read more about Amgen Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Patients With Solid Tumors At ESMO 2019
Heart Attack Survivors Are Taking Steps To Reduce Their Cardiovascular Risk. But Are They The Right Ones? Read more about Heart Attack Survivors Are Taking Steps To Reduce Their Cardiovascular Risk. But Are They The Right Ones?
Amgen To Webcast Investor Call At ESMO 2019 Read more about Amgen To Webcast Investor Call At ESMO 2019
Amgen Announces Positive Results From Two Phase 3 BLINCYTO® (blinatumomab) Studies In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia Read more about Amgen Announces Positive Results From Two Phase 3 BLINCYTO® (blinatumomab) Studies In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia
Amgen Showcases New Data From Oncology Pipeline And Portfolio At ESMO 2019 Read more about Amgen Showcases New Data From Oncology Pipeline And Portfolio At ESMO 2019
Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference Read more about Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference